This article was originally published in The Gray Sheet
Executive SummaryLaunches the SJM Regent mechanical heart valve the week of Feb. 22 in Europe and Canada following CE mark clearance, the firm announces Feb. 25. U.S. clinical trials will begin in the second quarter, St. Jude says, noting that the suprannular cuffed valve, made of pyrolytic carbon, is the first to be designed and developed with the assistance of supercomputer modeling
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.